These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7598710)

  • 1. Peptides from the amino-terminus of mouse mitochondrially encoded NADH dehydrogenase subunit 1 are potent chemoattractants.
    Shawar SM; Rich RR; Becker EL
    Biochem Biophys Res Commun; 1995 Jun; 211(3):812-8. PubMed ID: 7598710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical specificity of H-2M3a. Stereospecificity and space-filling requirements at position 1 maintain N-formyl peptide binding.
    Vyas JM; Shawar SM; Rodgers JR; Cook RG; Rich RR
    J Immunol; 1992 Dec; 149(11):3605-11. PubMed ID: 1431130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
    Rabiet MJ; Huet E; Boulay F
    Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
    Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
    J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutrophil chemotactic N-acetyl peptides from the calpain small subunit are also chemotactic for immunocytes.
    Kunimatsu M; Ma XJ; Ozaki Y; Narita M; Mizokami M; Sasaki M
    Biochem Mol Biol Int; 1995 Feb; 35(2):247-54. PubMed ID: 7663378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
    Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
    J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus.
    Dürr MC; Kristian SA; Otto M; Matteoli G; Margolis PS; Trias J; van Kessel KP; van Strijp JA; Bohn E; Landmann R; Peschel A
    Cell Microbiol; 2006 Feb; 8(2):207-17. PubMed ID: 16441432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.
    Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
    J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
    Dentino AR; Raj PA; De Nardin E
    Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines.
    Shen W; Proost P; Li B; Gong W; Le Y; Sargeant R; Murphy PM; Van Damme J; Wang JM
    Biochem Biophys Res Commun; 2000 May; 272(1):276-83. PubMed ID: 10872839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues.
    Derian CK; Solomon HF; Higgins JD; Beblavy MJ; Santulli RJ; Bridger GJ; Pike MC; Kroon DJ; Fischman AJ
    Biochemistry; 1996 Jan; 35(4):1265-9. PubMed ID: 8573582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
    Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
    Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors.
    Czapiga M; Gao JL; Kirk A; Lekstrom-Himes J
    Exp Hematol; 2005 Jan; 33(1):73-84. PubMed ID: 15661400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation.
    Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ
    J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immobilized chemoattractant peptides mediate adhesion and distinct calcium-dependent cell signaling in human neutrophils.
    Wetterö J; Hellerstedt T; Nygren P; Broo K; Aili D; Liedberg B; Magnusson KE
    Langmuir; 2008 Jun; 24(13):6803-11. PubMed ID: 18507416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
    Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
    Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal Advance: Interconversion between pure chemotactic ligands and chemoattractant/secretagogue ligands of neutrophil C5a receptor by a single amino acid substitution.
    Jia N; Semba U; Nishiura H; Kuniyasu A; Nsiama TK; Nishino N; Yamamoto T
    J Leukoc Biol; 2010 Jun; 87(6):965-75. PubMed ID: 20089669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
    Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
    J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase synthesis of chemotactic peptides using alpha-azido acids.
    Tornøe CW; Sengeløv H; Meldal M
    J Pept Sci; 2000 Jul; 6(7):314-20. PubMed ID: 10946996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.